Cardio Diagnostics Holdings, Inc. (CDIO): Net earnings per share (EPS TTM)

Cardio Diagnostics Holdings (CDIO) - corporate logo

Cardio Diagnostics (CDIO) has achieved a breakthrough in cardiology by identifying heart attack threats through epigenetic blood tests. The current rolling annual EPS value helps filter out market noise when searching for the business inflection point, where -2.53 determines the current status of the parameter. The implementation of AI screening in clinics ensures stable demand for consumables while management optimizes expenses amid limited capital.

CDIO Cardio Diagnostics Holdings, Inc. Net earnings per share for the last four quarters (04/28/2023 - 11/10/2026)

Summary analytical data breakdowns for Cardio Diagnostics Holdings Inc. (CDIO)

- current quotes and average value forecast:
Price Chart Cardio Diagnostics Holdings, Inc.|CDIO - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Cardio Diagnostics Holdings|CDIO - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Cardio Diagnostics|CDIO - Book Valuation of Business|Market Capitalization to Book Value Ratio cardiodiagnosticsinc.com|CDIO - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Cardio Diagnostics|CDIO - Long-Term Debt to Capital|Short-Term Debt to Equity Cardio Diagnostics Holdings, Inc.|CDIO - Aggregate Debt Obligations|Debts to Book Capitalization Cardio Diagnostics Holdings|CDIO - Company Long-Term Indebtedness|Company Short-Term Debts Cardio Diagnostics|Quick Liquidity cardiodiagnosticsinc.com
- earnings and multiples data:
CDIO - Company Net Income|Future Profit Cardio Diagnostics|CDIO - Company Value to Net Income|Forward P/E Multiple Cardio Diagnostics Holdings, Inc.|CDIO - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Cardio Diagnostics Holdings|CDIO - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Cardio Diagnostics|CDIO - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth cardiodiagnosticsinc.com|CDIO - Net earnings per share change in current year|Net earnings per share growth forecast for next year Cardio Diagnostics
General company analysis:cardiodiagnosticsinc.com (CDIO)
Manufactured products of Cardio Diagnostics Holdings, Inc.

Net income per share over 12 months reflects the actual portion of total income attributable to a single security. Investors evaluate capital management efficiency by analyzing the 12-month net income per share snapshot to forecast returns. Growth in this metric confirms the fundamental stability of the business. For Cardio Diagnostics (CDIO), this indicator correlates with the demand for genetic tests. The diversification of diagnostic solutions ensures a steady stream of profit.

Direct competitors

A - Earnings per share for the last twelve months|Net earnings per share for the last four quarters questdiagnostics.com DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months PerkinElmer|Bio-Rad Corp (BIO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) NNNN|Net earnings per share for the last 12 months soterahealth.com SHC|Net earnings per share (EPS TTM) QDEL (QuidelOrtho Corporation)|Net earnings per share (EPS TTM) OPKO Health Inc OPK|CDNA - Earnings per share for the last twelve months|Earnings per share for the trailing year MRVI (Maravai)|FLGT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months LAB|CTKB (Cytek Biosciences) - Net earnings per share (EPS TTM)|OraSure Technologies, Inc. (OSUR) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Exagen Inc. (XGN)|MDXH - Net earnings per one share for the last twelve months|Lucid Diagnostics Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year PRE|Insight Molecular - Net earnings per share (EPS TTM)|TRIB (Trinity Biotech plc) - Earnings per share for the last 12 months|PRPH: Net earnings per share (EPS TTM)|AIMD - Net earnings per share for the last four quarters|CODX (Co-Diagnostics, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) heartsciences.com|Net earnings per share (EPS TTM) BMRA|Onconetix Inc (ONCO) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Virax Biolabs Group Ltd VRAX|BJDX: Earnings per share for the last 12 months|AWH - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months acceleratediagnostics.com|Centogene N.V. (CNTG) - Earnings per share for the last twelve months|ENZ - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months FRES|GENE (GTG Labs) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) ME|Net earnings per share for the last four quarters psychemedics.com